OMNI Canaloplasty is a surgical option designed to unblock the flow of fluids that can cause dangerous pressure buildup in the eye. This OMNI Surgical System designed by Sight Sciences is an implant-free approach that targets three locations in the eye to reduce intraocular pressure (IOP).
Uses and Applications
The OMNI® Surgical System was developed for canaloplasty (viscodilation of Schlemm’s canal) and trabeculotomy (cutting of trabecular meshwork). The resulting increase in eye fluid drainage helps reduce eye pressure that leads to glaucoma. OMNI Canaloplasty effectively reduces potentially harmful pressure buildup in the eye caused by certain diseases.
- Primary Open-Angle Glaucoma
- High Interocular Eye Pressure
Features and Benefits
OMNI Canaloplasty involves a unique implant-free approach. Your surgeon will make a single, clear incision in the cornea and use a microcatheter to access Schlemm’s canal. Once inside, a reservoir controls the amount of viscoelastic fluid through intelligent engineering technology. Surgeons have the option of performing two procedures for canaloplasty and trabeculotomy using one device to relieve eye pressure.
- One minimally invasive glaucoma surgery (MIGS) – two procedures in one
- Three Points of Resistance – reduces eye pressure in all channels
- Implant-Free Procedure
How OMNI Compares to Alternative Treatments
The approach taken by most surgeons to release eye pressure is to target the conventional outflow pathway. Resistance is often found in the Trabecular Meshwork (50%-75%) and Schlemm’s canal and the distal collector channels (up to 50%). OMNI addresses resistance in all through channels with a single device using OMNI® Canaloplasty and Trabeculotomy.